Literature DB >> 3317802

New criteria for the diagnosis of ankylosing spondylitis.

J M Moll1.   

Abstract

Criteria for ankylosing spondylitis are useful for two main purposes. First, to provide unity of diagnosis in population surveys; secondly, in the field of therapeutic assessment. This paper is concerned with criteria used largely in the former role, i.e. as an epidemiological tool. Critical formulation and subsequent evaluation of criteria is important if a realistic measure of disease prevalence is to be obtained. The New York criteria have provided the general currency for diagnosis epidemiologically in recent years, but their value, in their originally published form, has been questioned for various reasons. Attempts have been made to improve these criteria or to suggest alternatives. Although increased sophistication of the original New York criteria has doubtless been achieved, the position regarding the diagnosis of ankylosing spondylitis continues to represent a challenge. The main concern is that the present "index of truth" for the disease, radiological sacroiliitis, is all too often a delayed feature, presenting only after pain has been present for some time. A second problem is the difficulty in diagnosing with confidence the early changes of sacroiliac sclerosis and erosion, and the degree of intra- and inter-observer error arising from these changes. Newer techniques such as radioisotope scintigraphy and computerised tomography (CT) are unlikely to replace the traditional pelvic radiograph. The way forward is more likely to be in the direction of how existing data are processed rather than what is used to obtain them. In this vein, suitable mathematical/biological models coupled with computer technology could provide realistic tools through a system of probability weighting of existing criteria.

Entities:  

Mesh:

Year:  1987        PMID: 3317802     DOI: 10.3109/03009748709102173

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  17 in total

1.  Health-related quality of life in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

2.  Bushen Qiangji Granule () medicated serum inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads signal pathway in vitro.

Authors:  Hong-Xiao Liu; Nan Jiang; Hui-Ying Liang; Ying-Yan Zhou; Xing-Hua Feng; Xiao-Yan Feng; He-Qiu Zhang; Zhi-Kui Wu; Quan Jiang; Jiao Fu; Xiao-Juan Ma; Peng Chen
Journal:  Chin J Integr Med       Date:  2016-10-26       Impact factor: 1.978

3.  Spinal mobility and its impact in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-11-06       Impact factor: 2.980

4.  Health-related Quality of Life Assessment on 100 Tunisian Patients with Ankylosing Spondylitis using the SF-36 Survey.

Authors:  Dhouha Azzouz; Mohamed Mehdi Ghannouchi; Manel Haouel; Samir Kochbati; Kaouthar Saadellaoui; Abdelmajid Ben Hmida; Béchir Zouari; Mohamed Montacer Kchir
Journal:  Oman Med J       Date:  2012-11

5.  Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis.

Authors:  Assia Laatiris; Bouchra Amine; Yousra Ibn Yacoub; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-12-15       Impact factor: 2.631

6.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

7.  Gender and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-07-28       Impact factor: 2.980

8.  Large-scale open trials with etodolac (Lodine) in France: an assessment of safety.

Authors:  C L Benhamou
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Coexistence of Familial Mediterranean Fever With Ankylosing Spondylitis and Sjogren's Syndrome: A Rare Occurrence.

Authors:  Fulya Dörtbaş; Yeşim Garip; Tuba Güler; Ayşe Aslıhan Karci
Journal:  Arch Rheumatol       Date:  2015-11-03       Impact factor: 1.472

10.  HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study).

Authors:  Mohamed Montacer Kchir; Wafa Hamdi; Lilia Laadhar; Samir Kochbati; Dhia Kaffel; Kaouthar Saadellaoui; Houria Lahmar; Mohamed Mehdi Ghannouchi; Dhouha Azzouz; Lilia Daoud; Abdelmajid Ben Hamida; Béchir Zouari; Mondher Zitouni; Sondes Makni
Journal:  Rheumatol Int       Date:  2009-08-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.